Generates revenue by selling and leasing its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) systems and related services used to treat mental health and addiction disorders under regulatory clearances.
Geographic Exposure
United States81%
Revenue Drivers
Deep TMS system sales
One-time sales of Deep TMS systems and add-on components.
CORE54.6%
Deep TMS system leasing
Fixed-fee leases providing customer access to Deep TMS systems.
CORE35.4%
Sale-related services
Services associated with sold systems, including support and related services.
PERIPHERAL8.3%
Other services
Additional service revenue not classified as sale-related services.
PERIPHERAL1.7%
End Markets
Psychiatrists and other physicians
Hospitals
Medical centers
Private clinics and clinic networks
Universities and research institutions
Specializations
FDA-cleared Theta Burst depression protocolSymptom provocation procedures (OCD and smoking)Multichannel rotational-field TMS (Deep TMS 360°) developmentAccelerated TMS treatment protocols (pilot studies)Post-marketing studies to support commercializationReimbursement coverage development with payors
Activities
Research & development and clinical trials for new indications
Manufacturing/assembly and supply-chain sourcing of system components
Direct sales, marketing, installation and training
Leasing operations and after-sales service/maintenance
